| 摘要: |
| 多囊卵巢综合征(PCOS)是育龄妇女最常见的内分泌疾病。 其发病机制复杂,包含生殖,内分泌,代谢和心理等各方面因素,因此多囊卵巢综合征的病因仍然未知。多囊卵巢综合征女性出现心血管疾病、骨质疏松症和癌症的风险较高,严重威胁女性的健康和生存质量。本文对改善和治疗多囊卵巢综合征常见的药物作用通路及靶点进行介绍,以便发现更好的治疗药物,改善多囊卵巢综合征患者的生活质量。 |
| 关键词: 多囊卵巢综合征 药物作用信号通路 靶点 胰岛素抵抗 研究进展 |
| DOI:10.13506/j.cnki.jpr.2020.10.008 |
| 基金项目:江苏省科技计划项目(No.SBK2019021355) |
|
|
|
| Research progress on drug action pathways and targets for treating polycystic ovary syndrome |
| HU Jie,HUANG Fang |
| (Department of Pharmacology of Chinese Materia Medica,Chinese Pharmacology and Department of Traditional Chinese Medicine,China Pharmaceutical University,Nanjing 211198,China) |
| Abstract: |
| Polycystic ovary syndrome( PCOS) is a common reproductive endocrine disorders in gynecology.Its pathogenesis is complex, including factors such as reproduction, endocrine, metabolism and psychology.The pathogenesis of polycystic ovary syndrome is still unknown. Women with polycystic ovary syndrome are at higher risk for cardiovascular disease, osteoporosis, and cancer, which has a significant impact on women's health and quality of life. This article introduced the pathways and targets for improving and treating polycystic ovary syndrome, in order to find better drugs to improve the patient's quality of life. |
| Key words: Polycystic ovary syndrome Signaling pathways of drug action Targets Insulin resistance Advances in research |